Hematology Oncology Cancer Hematology Oncology Cancer Genitourinary Cancers Bladder Cancer, Diagnosis and Treatment of - CancerNews Bladder Cancer: Diagnosis-Pathology-Etiology - PubMed, NLM Bladder Cancer - NCI, NIH Bladder Cancer - PubMed, NLM Bladder Cancer Screening - NCI, NIH Bladder Cancer Treatment - NCI, NIH Bladder Cancer Treatment - PubMed, NLM Extracranial Germ Cell Tumor (Childhood) Treatment - NCI, NIH  Extragonadal Germ Cell Tumors Treatment - NCI, NIH  Genitourinary, Cancer Management Guidelines: - British Columbia Cancer Agency Genitourinary Cancer - Merck Manual  Hormone-Refractory Prostate Cancer - National Comprehensive Cancer Network Guidelines HPC1 on chromosome 1 - Genome View, NCBI  Kidney Cancer - NCI, NIH Kidney (Renal Cell) Cancer - PubMed, NLM  Mechanisms of Hormone Resistance in Prostate Cancer - University of Michigan Penile Cancer - PubMed, NLM  Penile Cancer Treatment - NCI, NIH Prostate Cancer - BMJ Prostate Cancer - Genes and Disease, NCBI Prostate Cancer - LocusLink, NCBI Prostate Cancer, Maximal Androgen Blockade for the Treatment of Metastatic - Practice Guideline (.pdf) - Cancer Care Ontario, Canada Prostate Cancer - NCI, NIH Prostate Cancer - OMIM, NCBI Prostate Cancer Prevention - NCI, NIH   Prostate Cancer, Progress Review Groups - NCI Prostate Cancer - PubMed, NLM  Prostate Cancer, Screening for - NCI, NIH Prostate Cancer, The Use of Brachytherapy in T1 or T2 - Evidence Summary - Cancer Care Ontario, Canada Prostate Cancer, The Use of Conformal Radiotherapy and the Selection of Radiation Dose in T1 or T2 - Practice Guideline - Cancer Care Ontario, Canada Prostate Cancer Treatment - NCI, NIH Prostate Cancer: Treatment - PubMed, NLM  Prostatic Cancer, Relative Effectiveness and Cost-Effectiveness of Methods of Androgen Suppression in the Treatment of Advanced - University of Michigan Health System Prostate Metastatic to Bone, Use of Strontium89 in Patients with Endocrine-Refractory Carcinoma of the - Practice Guidelines - Cancer Care Ontario, Canada PSA Test in Early Detection of Prostate Cancer, The - Health Services Utilization and Research Commission  Renal Cell Cancer Treatment - NCI, NIH Renal Neoplasms, Obstruction and Lower Urinary Tract - University of Arkansas for Medical Sciences Testicular Cancer - PubMed, NLM  Testicular Cancer, Screening for - NCI, NIH Testicular Cancer, Surveillance Programs for Early Stage Non-Seminomatous - Practice Guidelines - Cancer Care Ontario, Canada Testicular Cancer Treatment - NCI, NIH Testicular Tumors - OMIM, NCBI  Transitional Cell Cancer (Renal and Ureter) Treatment - NCI, NIH Transitional Cell Carcinoma of the Bladder or Urothelium, Use of Chemotherapy in Advanced Unresectable or Metastatic - Practice Guidelines - Cancer Care Ontario, Canada Transitional Cell Carcinoma of the Bladder, Use of Adjuvant Chemotherapy Following Cystectomy in Patients with Deep Muscle-Invasive - Practice Guideline - Cancer Care Ontario, Canada Transitional Cell Carcinoma of the Bladder, Use of Neoadjuvant Chemotherapy in - Practice Guidelines - Cancer Care Ontario, Canada Transitional Cell Carcinoma of the Urinary Tract - PubMed, NLM Ureter, Cancer of - OMIM, NCBI  Urethral Cancer Treatment - NCI, NIH  Wilms' Tumor and Other Childhood Tumors Treatment - NCI, NIH Wilms' Tumor - PubMed, NLM Updated 04/16/03